Turning Biological Science into Sales
Whitney at a Glance
Whitney Rottman is known for her contagious energy, fierce clarity, and no-BS approach to complex problems that demand forward motion. She brings together scientific depth and commercial discipline to help ag-biological companies turn promising technologies into products that actually sell.
Communication, strategic boundary-setting, and a relentless focus on outcomes define how Whitney builds focused teams and guides leadership through the complexity of launching microbial products in agriculture.
Her work centers on a simple reality: ag-biologicals cannot be sold using a chemistry-era playbook.
From Physiology to Commercialization Strategy
Whitney’s superpower is the ability to take complex biological processes and translate them into clear, actionable insights that support real-world adoption.
With an MSc from Penn State University, Whitney studied the intersection of circadian biology, nutritional physiology, and rumen physiology. Her research explored how biological systems can be influenced to drive measurable outcomes—in this case, altering milk production and milk components by influencing feeding behavior.
This work revealed an important principle that continues to shape Whitney’s approach today: microbial systems are the gatekeepers of biological change.
In ruminant animals, the rumen microbiome determines how nutrition translates into production. In agriculture, the soil microbiome plays a similar role, shaping how crops respond to inputs and environmental conditions.
After graduate school, Whitney joined a research greenhouse as a scientist for a multinational biological solutions company. There, she applied her understanding of physiology to plant systems, working with microbes and microbially derived products in complex agricultural environments.
This experience sharpened her ability to translate biological mechanisms into practical outcomes—an ability that would later become central to her work with commercialization and sales strategy.
Bridging Science, Business, and the Field
After earning her MBA from Loyola University Maryland, Whitney founded Wildflower Ventures.
Her goal was to close a persistent gap in the ag-biological industry: the disconnect between scientific discovery, business strategy, and how farmers actually adopt products in the field.
Too often, promising biological technologies stall during commercialization. Sales teams are expected to explain complex microbial science using outdated chemistry-based selling tactics.
Whitney helps leadership teams solve this problem by developing biology-based sales playbooks that align product truth, claims strategy, and commercial execution.
Today, she works with founders, CEOs, boards, and investors across plant and animal agriculture to ensure microbial products launch with credibility and, more importantly. gain traction in the market.
The Three Pillar Approach for Biological Commercialization
Whitney’s approach to commercialization is both structured and adaptable. It is built around a repeatable framework known as the Three Pillars of Biological Product Development:
Product Registration
Ensuring claims and regulatory pathways support long-term commercialization.
Mode of Action and Efficacy
Building scientific clarity around how the biological works and where it performs best.
Sales and Marketing Execution
Translating microbial science into credible sales conversations that hold up in the field.
This framework helps companies avoid a common trap in ag-biologicals getting to launch and not having enough of the science story to truly sell the product. By aligning these three pillars early, Whitney helps teams launch products that are not only scientifically sound but commercially viable.
How Whitney Supports Clients
Whitney partners with ag-biological companies through a combination of workshops, strategic advisory, and fractional leadership support.
She helps companies:
Diagnose why biological products are not gaining traction in the market
Replace chemistry-based sales tactics with biology-based sales strategies
Align product development decisions with commercialization outcomes
Translate complex microbial science into credible sales stories
Strengthen distributor and dealer enablement
Provide temporary leadership coverage so teams maintain commercial momentum
Her work ultimately ensures that sales teams are equipped with a playbook that matches how biological products actually work.
Wildflower Ventures
Wildflower Ventures is a commercialization advisory firm serving small to mid-sized companies in the ag-biological and animal health industries.
Whitney helps leadership teams replace outdated chemistry-era thinking with biology-based commercialization strategies that align product truth, scientific evidence, and sales execution.
Because in biologicals, every decision—from the lab bench to the field trial—eventually shows up in a sales conversation.